4/A//SEC Filing
Reyes Joyce 4/A
Accession 0001209191-23-026138
CIK 0001383701other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 6:56 PM ET
Size
16.3 KB
Accession
0001209191-23-026138
Insider Transaction Report
Form 4/AAmended
Histogen Inc.HSTO
Reyes Joyce
See Remarks
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2023-03-10−4,452→ 0 totalExercise: $4.80Exp: 2032-02-17→ Common Stock (4,452 underlying) - Award
Stock Option (right to buy)
2023-03-10+47,417→ 47,417 totalExercise: $0.95Exp: 2033-03-10→ Common Stock (47,417 underlying) - Award
Stock Option (right to buy)
2023-03-10+16,659→ 16,659 totalExercise: $0.95Exp: 2033-03-10→ Common Stock (16,659 underlying) - Disposition to Issuer
Stock Option (right to buy)
2023-03-10−1,200→ 0 totalExercise: $4.80Exp: 2032-02-17→ Common Stock (1,200 underlying) - Disposition to Issuer
Stock Option (right to buy)
2023-03-10−7,833→ 0 totalExercise: $3.20Exp: 2032-06-01→ Common Stock (7,833 underlying)
Footnotes (7)
- [F1]1/4 of the shares subject to the option vest one year after the date of grant, on 3/10/2024, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
- [F2]The shares subject to this option are subject to forfeiture in the event that the shares available pursuant to the Plan are not increased prior to the one-year anniversary and vesting of the award by an amount required to be available for issuance for all outstanding stock awards containing this forfeiture condition.
- [F3]Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.
- [F4]On March 10, 2023, the Issuer and the Reporting Person agreed to cancel the stock option award.
- [F5]1/4 of the shares subject to the option vested on 9/15/2022 and the remaining 1/36 of the shares vest on a monthly basis thereafter.
- [F6]1/4 of the shares subject to the option vested on 11/8/2022 and the remaining 1/36 of the shares vest on a monthly basis thereafter.
- [F7]1/4 of the shares subject to the option vest one year after the date of grant, on 6/1/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
Documents
Issuer
Histogen Inc.
CIK 0001383701
Entity typeother
Related Parties
1- filerCIK 0001929891
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 6:56 PM ET
- Size
- 16.3 KB